Osipov Ivan D, Zaporozhchenko Ivan A, Bondar Anna A, Zaripov Marat M, Voytsitskiy Vladimir E, Vlassov Valentin V, Laktionov Pavel P, Morozkin Evgeny S
Novosibirsk State University, Novosibirsk, Russia.
Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia.
Adv Exp Med Biol. 2016;924:9-12. doi: 10.1007/978-3-319-42044-8_2.
Expression levels of five miRNAs (miR-19b, miR-21, miR-126, miR-141, miR-205) were measured in the plasma of healthy donors and prostate cancer patients. It was shown that miR-141 expression level efficiently discriminates early stage prostate cancer patients and correlates with the Gleason score.
在健康供体和前列腺癌患者的血浆中检测了五种微小RNA(miR-19b、miR-21、miR-126、miR-141、miR-205)的表达水平。结果显示,miR-141的表达水平能够有效区分早期前列腺癌患者,并且与 Gleason评分相关。